Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use
- PMID: 10558954
- DOI: 10.1086/315148
Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use
Abstract
Recent studies of the human Pneumocystis carinii dihydropteroate synthase (DHPS) gene suggest that P. carinii is developing resistance to sulfamethoxazole (SMX) and dapsone. To explore whether P. carinii is also developing resistance to trimethoprim (TMP), the human P. carinii dihydrofolate reductase (DHFR) gene was cloned, DHFR and DHPS genes in 37 P. carinii isolates from 35 patients were sequenced, and the relationship between TMP-SMX or dapsone use and gene mutations was analyzed. The DHFR gene sequences were identical in all isolates except 1 with a synonymous substitution. In contrast, the DHPS gene sequences showed mutations in 16 of the 37 isolates; prior sulfa/sulfone prophylaxis was associated with the presence of these mutations (P<.001). In addition to suggesting that there is less selective pressure on DHFR than on DHPS, this study reinforces the hypothesis that mutations in the DHPS gene are likely involved in the development of sulfa resistance in P. carinii.
Similar articles
-
Genetic diversity of drug targets including dihydropteroate synthase, dihydrofolate reductase and cytochrome b, in Pneumocystis carinii f. sp. hominis isolates in Japan.Res Commun Mol Pathol Pharmacol. 2002;112(1-4):159-76. Res Commun Mol Pathol Pharmacol. 2002. PMID: 15080506
-
Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients.J Infect Dis. 2000 Aug;182(2):551-7. doi: 10.1086/315719. Epub 2000 Jul 28. J Infect Dis. 2000. PMID: 10915088 Clinical Trial.
-
Mutations in the dihydropteroate synthase gene of human-derived Pneumocystis carinii isolates from Italy are infrequent but correlate with prior sulfa prophylaxis.J Infect Dis. 2002 May 15;185(10):1530-2. doi: 10.1086/340220. Epub 2002 Apr 30. J Infect Dis. 2002. PMID: 11992293
-
Dihydropteroate synthase gene mutations in Pneumocystis and sulfa resistance.Emerg Infect Dis. 2004 Oct;10(10):1721-8. doi: 10.3201/eid1010.030994. Emerg Infect Dis. 2004. PMID: 15504256 Free PMC article. Review.
-
[New aspects of epidemiology and treatment of Pneumocystis carinii infection].Pol Merkur Lekarski. 2004 Nov;17(101):534-7. Pol Merkur Lekarski. 2004. PMID: 15754652 Review. Polish.
Cited by
-
Multilocus sequence typing of Pneumocystis jirovecii from clinical samples: how many and which loci should be used?J Clin Microbiol. 2013 Sep;51(9):2843-9. doi: 10.1128/JCM.01073-13. Epub 2013 Jun 19. J Clin Microbiol. 2013. PMID: 23784120 Free PMC article.
-
Rapid detection of mutations in the human-derived Pneumocystis carinii dihydropteroate synthase gene associated with sulfa resistance.Antimicrob Agents Chemother. 2001 Mar;45(3):776-80. doi: 10.1128/AAC.45.3.776-780.2001. Antimicrob Agents Chemother. 2001. PMID: 11181359 Free PMC article.
-
Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium.Antibiotics (Basel). 2020 Dec 8;9(12):877. doi: 10.3390/antibiotics9120877. Antibiotics (Basel). 2020. PMID: 33302565 Free PMC article. Review.
-
A Molecular Window into the Biology and Epidemiology of Pneumocystis spp.Clin Microbiol Rev. 2018 Jun 13;31(3):e00009-18. doi: 10.1128/CMR.00009-18. Print 2018 Jul. Clin Microbiol Rev. 2018. PMID: 29899010 Free PMC article. Review.
-
Anti-folate combination therapies and their effect on the development of drug resistance in Plasmodium vivax.Sci Rep. 2013;3:1008. doi: 10.1038/srep01008. Epub 2013 Jan 7. Sci Rep. 2013. PMID: 23301149 Free PMC article.
MeSH terms
Substances
Associated data
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources